Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News

$Precision BioSciences(DTIL.US)$ TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision's Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune Diseases
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
5558 Views
Comment
Sign in to post a comment
    1897Followers
    30Following
    23KVisitors
    Follow